Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 6—June 2007

Research

Isolation and Characterization of Novel Human Parechovirus from Clinical Samples

Kanako Watanabe*†, Masayasu Oie*, Masaya Higuchi*, Makoto Nishikawa†, and Masahiro Fujii*Comments to Author 
Author affiliations: *Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; †Niigata Prefectural Institute of Public Health and Environmental Sciences, Niigata, Japan

Main Article

Table 1

Neutralization activities of anti-HPeV antibodies using Vero cells*

Antiserum Virus
NII561-2000 HPeV-1 HPeV-2 HPeV-3
NII561-2000 160 10 <10 <10
HPeV-1† <10 >1,280 <10 <10
HPeV-2 <10 <10 160 <10
HPeV-3 <10 <10 <10 >1,280

*HPeV, human parechovirus.
†The HPeV strains used were Harris strain for HPeV-1, Williamson strain for HPeV-2, and A308/99 for HPeV-3.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO